SiRNA-mediated silencing of integrin β3 expression inhibits the metastatic potential of B16 melanoma cells

Oncology Reports

Volumn 28, Issue 5, 2012, Pages 1567-1573

  Nasulewicz Goldeman, Anna ^a   Uszczyńska, Barbara ^a   Szczaurska Nowak, Katarzyna ^a   Wietrzyk, Joanna ^a  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

Author keywords

Integrins; Metastasis; Mouse melanoma; RNA interference; SiRNA

Indexed keywords

ALPHA3 INTEGRIN; FIBRONECTIN; MATRIGEL; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IN VITRO STUDY; IN VIVO GENE TRANSFER; IN VIVO STUDY; LUNG METASTASIS; MELANOMA; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SKIN CARCINOGENESIS;

ANIMALS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FIBRONECTINS; INTEGRIN BETA3; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 84866452621     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.1963     Document Type: Article

References (29)

1. Albelda SM, Mette SA, Elder DE, Stewart R, Damjanovich L, Herlyn M and Buck CA: Integrin distribution in malignant melanoma: association of the β3 subunit with tumor progression. Cancer Res 50: 6757-6764, 1990. (Pubitemid 20348810)
2. Hieken TJ, Farolan M, Ronan SG, Shilkaitis A, Wild L and Das Gupta TK: β3 integrin expression in melanoma predicts subsequent metastasis. J Surg Res 63: 169-173, 1996. (Pubitemid 26197726)
3. Trikha M, Timar J, Zacharek A, Nemeth JA, Cai Y, Dome B, Somlai B, Raso E, Ladanyi A and Honn KV: Role for β3 integrins in human melanoma growth and survival. Int J Cancer 101: 156-167, 2002. (Pubitemid 34970908)
4. Cooper CR, Chay CH and Pienta KJ: The Role of alpha(v)beta(3) in prostate cancer progression. Neolplasia 4: 191-194, 2002. (Pubitemid 34525250)
5. Rezaeipoor R, Chaney EJ, Oldenburg AL and Boopart S: Expression order of alpha-v and beta-3 integrin subunits in the N-methyl-N-nitrosourea-induced rat mammary tumor model. Cancer Invest 27: 496-503, 2009.
6. Leu SJ, Lam SC and Lau LF: Pro-angiogenic activities of CYR61 (CCN1) mediated through integrins avb3 and a6b1 in human umbilical vein endothelial cells. J Biol Chem 277: 46248-46255, 2002.
7. Nam JO, Kim JE, Jeong HW, Lee SJ, Lee BH, Choi JY, Park RW, Park JY and Kim IS: Identification of the αvβ3 integrin-interacting motif of βig-h3 and its anti-angiogenic effect. J Biol Chem 278: 25902-25909, 2003. (Pubitemid 36835352)
8. Mizejewski GJ: Role of integrins in cancer: survey of expression patterns. Proc Soc Exp Biol Med 222: 124-138, 1999.
9. Minamiguchi K, Kumagai H, Masuda T, Kawada M, Ishizuka M and Takeuchi T: Thiolutin, an inhibitor of HUVEC adhesion to vitronectin, reduces paxillin in HUVECs and suppresses tumour cell-induced angiogenesis. Int J Cancer 93: 307-316, 2001. (Pubitemid 32592047)
10. Nikos E, Tsopanoglou NE, Andriopoulou P and Maragoudakis ME: On the mechanism of thrombin-induced angiogenesis: involvement of αvβ3- integrin. Am J Physiol Cell Physiol 283: 1501-1510, 2002.
11. Burns GF, Cosgrove L, Triglia T, Beall JA, Lopez AF, Werkmeister JA, Begley CG, Haddad AP, d'Apice AJ, Vadas MA, et al: The IIb-IIIa glycoprotein complex that mediates platelet aggregation is directly implicated in leukocyte adhesion. Cell 45: 269-280, 1986. (Pubitemid 16043430)
12. Timar J, Trikha M, Szekeres K, Bazaz R, Tovari J, Silletti S, Raz A and Honn KV: Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion. Cancer Res 56: 1902-1908, 1996. (Pubitemid 26118230)
13. Oleksowicz L, Mrowiec Z, Schwartz E, Khorshidi M, Dutcher J and Puszkin E: Characterization of tumour-induced platelet aggregation: the role of immunorelated GPIb and GPIIb/IIIa expression by MCF-7 breast cancer cells. Thromb Res 79: 261-274, 1995.
14. Sheu JR, Lin CH, Peng HC and Huang TF: Triflavin, an Arg-Gly- Asp-containing peptide, inhibits human cervical carcinoma (HeLa) cell-substratum adhesion through an RGD-dependent mechanism. Peptides 15: 1391-1398, 1994. (Pubitemid 24381185)
15. Yun Z, Menter DG and Nicolson GL: Involvement of integrin alphavbeta3 in cell adhesion, motility, and liver metastasis of murine RAW117 large cell lymphoma. Cancer Res 56: 3103-3111, 1996.
16. Cohen SA, Trikha M and Mascelli MA: Potential future clinical applications for the GPIIb/IIIa antagonist, abciximab in thrombosis, vascular and oncological indications. Pathol Oncol Res 6: 163-174, 2000.
17. Auzzas L, Zanardi F, Battistini L, Burreddu P, Carta P, Rassu G, Curti C and Casiraghi G: Targeting alphavbeta3 integrin: design and applications of mono- and multifunctional RGD-based peptides and semipeptides. Curr Med Chem 17: 1255-1299, 2010.
18. Skehan P, Storeng R, Sudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR: New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107-1112, 1990. (Pubitemid 20213250)
19. Chang YS, Chen YQ, Timar J, Nelson KK, Grossi IM, Fitzgerald LA, Diglio CA and Honn KV: Increased expression of alpha IIb beta 3 integrin in subpopulations of murine melanoma cells with high lung-colonizing ability. Int J Cancer 51: 445-451, 1992.
20. Van Belle PA, Elenitsas R, Satyamoorthy K, Wolfe JT, Guerry DI, Schuchter L, Van Belle TJ, Albelda S, Tahin P, Herlyn M and Elder DE: Progression-related expression of beta3 integrin in melanomas and nevi. Hum Pathol 33: 562-567, 1999. (Pubitemid 29218051)
21. Perdih A and Dolenc MS: Small molecule antagonists of integrin receptors. Curr Med Chem 17: 2371-2392, 2010.
22. Brooks PC, Stromblad S, Klemke R, Visscher D, Sarkar FH and Cheresh DA: Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Invest 96: 1815-1822, 1995.
23. Mitjans F, Meyer T, Fittschen C, Goodman S, Jonczyk A, Marshall JF, Reyes G and Piulats J: In vivo therapy of malignant melanoma by means of antagonists of αv integrins. Int J Cancer 87: 716-723, 2000. (Pubitemid 30620415)
24. Isoai A, Ueno Y, Giga-Hama Y, Goto H and Kumagai HA: A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis. Cancer Lett 65: 259-264, 1992.
25. Buerkle MA, Pahernik SA, Sutter A, Jonczyk AKM and Dellian M: Inhibition of the alpha-nu integrins with a cyclic RGD peptide impairs angiogenesis, growth and metastasis of solid tumours in vivo. Br J Cancer 86: 788-795, 2002. (Pubitemid 34250824)
26. Perkins JJ, Duong LT, Fernandez-Metzler C, Hartman GD, Kimmel DB, Leu C-T, Lynch JJ, Prueksaritanont T, Rodan GA, Rodan SB, et al: Non-peptide alpha(v)beta(3) antagonists: identification of potent, chain-shortened RGD mimetics that incorporate a central pyrrolidinone constraint. Bioorg Med Chem Lett 13: 4285-4288, 2003. (Pubitemid 37490804)
27. Han HD, Mangala LS, Lee JW, Shahzad MM, Kim HS, Shen D, Nam EJ, Mora EM, Stone RL, Lu C, et al: Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clin Cancer Res 16: 3910-3922, 2010.
28. Roman J, Ritzenthaler JD, Roser-Page S, Sunx and Han S: Alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer. Am J Respir Cell Mol Biol 43: 684-691, 2010.
29. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998. (Pubitemid 28099681)